CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows used in operating activities:
Net loss	$ (18,584)	$ (29,462)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	88	91
Amortization of intangibles	9,806	18,485
Amortization of deferred financing costs	950	620
Accretion expense	1,205	1,348
PIK Interest	466	0
Stock compensation expense	400	745
Fair market value change in contingent consideration	263	346
Fair market value change in derivative liability	19	354
(Increase) decrease in operating assets:
Accounts receivable	8,311	19,729
Income tax receivable	55	734
Inventory	(11)	331
Prepaid expenses and other assets	1,337	(720)
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	(1,904)	(1,764)
Accrued allowances	3,946	(5,151)
Interest payable	(4,897)	(4,568)
Other liabilities	(1,717)	(1,918)
Net cash used in operating activities	(267)	(800)
Cash flows from investing activities:
Purchase of software and equipment	(4)	(3)
Net cash used in investing activities	(4)	(3)
Cash flows from financing activities:
Payments on Treximet Secured Notes	(5,373)	(12,812)
Payment on financing costs	(221)	0
Payments on mortgages and capital leases	(13)	(23)
Net cash used in financing activities	(5,607)	(12,835)
Net decrease in cash and cash equivalents	(5,878)	(13,638)
Cash and cash equivalents, beginning of period	32,820	36,375
Cash and cash equivalents, end of period	$ 26,942	$ 22,737